Panos Stathopoulos

2.1k total citations
38 papers, 1.4k citations indexed

About

Panos Stathopoulos is a scholar working on Neurology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Panos Stathopoulos has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 13 papers in Pathology and Forensic Medicine and 7 papers in Immunology. Recurrent topics in Panos Stathopoulos's work include Peripheral Neuropathies and Disorders (22 papers), Myasthenia Gravis and Thymoma (15 papers) and Multiple Sclerosis Research Studies (12 papers). Panos Stathopoulos is often cited by papers focused on Peripheral Neuropathies and Disorders (22 papers), Myasthenia Gravis and Thymoma (15 papers) and Multiple Sclerosis Research Studies (12 papers). Panos Stathopoulos collaborates with scholars based in United States, Greece and United Kingdom. Panos Stathopoulos's co-authors include Kevin C. O’Connor, Richard J. Nowak, Marinos C. Dalakas, Andreas Kyrozis, Dimitrios Vassilopoulos, Antonia Trichopoulou, Harry Alexopoulos, Θεοδώρα Ψαλτοπούλου, Steven H. Kleinstein and D Trichopoulos and has published in prestigious journals such as The Journal of Experimental Medicine, Bioinformatics and The Journal of Immunology.

In The Last Decade

Panos Stathopoulos

36 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Panos Stathopoulos United States 22 808 290 240 220 167 38 1.4k
Ludo Vanopdenbosch Belgium 14 388 0.5× 450 1.6× 152 0.6× 75 0.3× 246 1.5× 50 1.2k
Elisabetta Zardini Italy 19 446 0.6× 442 1.5× 66 0.3× 180 0.8× 220 1.3× 43 1.1k
Robert Hoepner Switzerland 19 324 0.4× 543 1.9× 169 0.7× 169 0.8× 178 1.1× 96 1.1k
Fuhua Peng China 18 257 0.3× 418 1.4× 160 0.7× 168 0.8× 245 1.5× 80 1.1k
Carolina Ionete United States 16 251 0.3× 495 1.7× 70 0.3× 277 1.3× 491 2.9× 51 1.3k
Sarah Laurent Germany 13 371 0.5× 360 1.2× 120 0.5× 213 1.0× 76 0.5× 19 828
Suzanne Gazda United States 9 273 0.3× 621 2.1× 48 0.2× 362 1.6× 59 0.4× 13 1.0k
Amanda Cox United States 18 470 0.6× 809 2.8× 33 0.1× 564 2.6× 163 1.0× 45 1.8k
Anne‐Katrin Pröbstel Switzerland 16 495 0.6× 401 1.4× 114 0.5× 233 1.1× 238 1.4× 32 1.1k
Jonatan Salzer Sweden 21 638 0.8× 1.6k 5.5× 158 0.7× 537 2.4× 201 1.2× 49 2.1k

Countries citing papers authored by Panos Stathopoulos

Since Specialization
Citations

This map shows the geographic impact of Panos Stathopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panos Stathopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panos Stathopoulos more than expected).

Fields of papers citing papers by Panos Stathopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panos Stathopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panos Stathopoulos. The network helps show where Panos Stathopoulos may publish in the future.

Co-authorship network of co-authors of Panos Stathopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Panos Stathopoulos. A scholar is included among the top collaborators of Panos Stathopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panos Stathopoulos. Panos Stathopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vakrakou, Aigli G., Panos Stathopoulos, Maria‐Eleftheria Evangelopoulos, et al.. (2023). Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice. International Immunopharmacology. 125(Pt B). 111192–111192.
2.
Kazakou, Paraskevi, Aigli G. Vakrakou, John S. Tzartos, et al.. (2023). Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study. Clinical and Experimental Medicine. 23(6). 2885–2894. 8 indexed citations
3.
Stathopoulos, Panos & Marinos C. Dalakas. (2022). The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders. Expert Review of Clinical Immunology. 18(9). 933–945. 12 indexed citations
4.
Stefanis, Leonidas, et al.. (2022). B-Cell-Directed Therapies: A New Era in Multiple Sclerosis Treatment. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50(3). 355–364. 8 indexed citations
5.
Vakrakou, Aigli G., et al.. (2022). The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data. International Journal of Molecular Sciences. 23(15). 8077–8077. 36 indexed citations
6.
Stathopoulos, Panos & Marinos C. Dalakas. (2022). Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases. Neurotherapeutics. 19(3). 691–710. 37 indexed citations
7.
Tzartos, John S., Aigli G. Vakrakou, Marianthi Breza, et al.. (2021). Cortical involvement and leptomeningeal inflammation in myelin oligodendrocyte glycoprotein antibody disease: A three-dimensional fluid-attenuated inversion recovery MRI study. Multiple Sclerosis Journal. 28(5). 718–729. 8 indexed citations
8.
Vakrakou, Aigli G., Maria‐Eleftheria Evangelopoulos, G. Fragoulis, et al.. (2021). IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients. Journal of Neuroimmunology. 361. 577759–577759. 4 indexed citations
9.
Jiang, Ruoyi, Miriam L. Fichtner, Kenneth B. Hoehn, et al.. (2020). Single-cell repertoire tracing identifies rituximab-resistant B cells during myasthenia gravis relapses. JCI Insight. 5(14). 44 indexed citations
10.
Fichtner, Miriam L., Rachel L. Redler, Ruoyi Jiang, et al.. (2020). Affinity maturation is required for pathogenic monovalent IgG4 autoantibody development in myasthenia gravis. The Journal of Experimental Medicine. 217(12). 21 indexed citations
11.
Stathopoulos, Panos, Alanna Ritchie, John Soltys, et al.. (2019). Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production. Brain. 142(6). 1598–1615. 74 indexed citations
12.
Stathopoulos, Panos, Patrick Waters, Sarosh R. Irani, et al.. (2019). Autoantibodies against Neurologic Antigens in Nonneurologic Autoimmunity. The Journal of Immunology. 202(8). 2210–2219. 21 indexed citations
13.
Takata, Kazushiro, Panos Stathopoulos, Michelangelo Cao, et al.. (2019). Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients. JCI Insight. 4(12). 48 indexed citations
14.
Stathopoulos, Panos, Aditya Kumar, Jason A. Vander Heiden, et al.. (2018). Mechanisms underlying B cell immune dysregulation and autoantibody production in MuSK myasthenia gravis. Annals of the New York Academy of Sciences. 1412(1). 154–165. 36 indexed citations
15.
Heiden, Jason A. Vander, Panos Stathopoulos, Julian Q. Zhou, et al.. (2017). Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep Sequencing. The Journal of Immunology. 198(4). 1460–1473. 75 indexed citations
16.
Psychogios, Klearchos, et al.. (2015). The Pathophysiological Mechanism Is an Independent Predictor of Long-Term Outcome in Stroke Patients with Large Vessel Atherosclerosis. Journal of Stroke and Cerebrovascular Diseases. 24(11). 2580–2587. 12 indexed citations
17.
Stathopoulos, Panos, Harry Alexopoulos, & Marinos C. Dalakas. (2015). Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders. Nature Reviews Neurology. 11(3). 143–156. 87 indexed citations
18.
Stathopoulos, Panos, et al.. (2014). Search For Autoantibodies Targeting The Nodes Of Ranvier In Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) (P1.028). Neurology. 82(10_supplement). 2 indexed citations
19.
Ψαλτοπούλου, Θεοδώρα, Andreas Kyrozis, Panos Stathopoulos, et al.. (2008). Diet, physical activity and cognitive impairment among elders: the EPIC–Greece cohort (European Prospective Investigation into Cancer and Nutrition). Public Health Nutrition. 11(10). 1054–1062. 130 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ludo Vanopdenbosch Breakdown of academic impact, for papers by Elisabetta Zardini Breakdown of academic impact, for papers by Robert Hoepner Breakdown of academic impact, for papers by Fuhua Peng Breakdown of academic impact, for papers by Carolina Ionete Breakdown of academic impact, for papers by Sarah Laurent Breakdown of academic impact, for papers by Suzanne Gazda Breakdown of academic impact, for papers by Amanda Cox Breakdown of academic impact, for papers by Anne‐Katrin Pröbstel Breakdown of academic impact, for papers by Jonatan Salzer
Rankless by CCL
2026